Neuropharmacology of Psychactive Drugs
AKA Notes on drug assisted mood therapy from the Psychedelic Science Conference
The bulk of these notes are from presentations by researchers at the University of Zurich. The findings were echoed in research posters from UCSF.
The presentations were very informative, but maybe 1/10th of the room could follow them. Brain science is complex. To help relay the information to people who wanted to use it - psychologists or people in the media, and a few friends interested in personal exploration - I translated notes on what was being said. I was mostly able to do this because I studied neuropharmacology for four years at a large US University and am good with my shorthand :) I think it is important that this information reaches the public in a way that is both true to the data and understandable.
The notes seem helpful for highlighting the mechanisms of how substances and therapy can impact treatment resistance mood disorders such as PTSD, Depression, and Anxiety.
For ease of reference, "drug treatment" will refer to hallucinogens (LSD, mushrooms, ayahuasca/DMT) and dissociatives (ibogaine, ketamine)."Mood disorders" will refer to PTSD, Depression, and Anxiety.
I. Dual therapy of drug + guidance is necessary for drug treatment to be effective on mood disorders. Neurologically speaking, taking one of these drugs alone won't permanently impact a mood disorder. The drug assists in rewiring the circuitry of the brain, essentially pulling a bunch of phone chargers out of the wall and putting them in a pile. Research is showing an external guide has to come along and reorganize them for a -lasting- beneficial effect to stick. Guidance, particularly from a professional therapist, is crucial for a timely and effective treatment.
II. Drug therapy works on treatment resistant mood disorders. In clinical psych, 1/3 of patients respond well to pharmaceutical treatments, 1/3 must vary their prescriptions to get any relief, and 1/3 are deemed treatment resistant - there is no chemical combination that will lessen the negative impact of their mood disorder. This is known as "the rule of thirds." These treatments have been shown to be effective for those in the final third, potentially bringing relief and hope to millions who suffer from mood disorder disabilities.
III. Taking a drug induces a state of enhanced learning and forgetting in the brain, known as plasticity. Children have very plastic, or flexible, circuit paths in the brain, helping them to learn and either retain or forget information quickly. Adults have some ability to do so, but much less due to the changes in the brain between childhood and adulthood. Drugs, neurologically speaking, induce a temporary childlike period of learning.
IV. Upcoming research suggests the time period for enhanced learning varies by drug, and is most potent at one week, fading in most cases by six months. (Posters)
V. It is at this point dual therapy (drug + guidance) overtakes monotherapy (drug only) for relief. (Posters)
VI. The enhanced learning state is due to a chemical called BDNF, which helps create new brain cells and electrical patterns in children. Glutamate, a sugar, is also present.
VII. Hallucinogens and Dissociative drugs use different routes, yet both produce the same chemical, BDNF. This is quite unexpected. You can think of it as both an apple and a pumpkin having seeds.
VIII. The main effect of hallucinogens comes from a site in the brain called 5HT2a, a specific serotonin receptor. This was proven by blocking it with the drug Ketansenin and noting the majority of effects were diminished without its use. (Receptors activated by the hallucinogens in LSD, DMT, and mushrooms are 5HT1a, 5HT1b, 5HT2a, 5HT2c, 5HT6, 5HT7, D2, and D1R)
IX. The chemical pathways are
Hallucinogens > 5HT2A activation > glutamate > BDNF > learning period
Dissociatives > NMDA antagonist (block) on GABA (an inhibiting chemical), for a net positive stimulation effect > glutamate > BDNF > learning period
Normally, drugs branch from their similarities like a family tree. One parent metabolizes into its child chemicals down the line, they go to their chemical specific sites, and that's that. There's little, if any, overlap in brain chemical production. These two (5HT and NMDA) don't even have a similar parent.
Audible gasps went around. This research, as I saw repeated over and over again for each drug from other research groups, showed multichemical causality with one final result. Both hallucinogens and dissociatives produce BDNF.
X. Hallucinogens are more potent, with less side effects.
XI. LSD FX
The descriptions used were activity vs connectivity and integration vs disintegration. I translated this to "local activity" vs "global activity" (across varies places in the brain). The speaker agreed this was an accurate way to speak about it. I'm going to use it. For reference, sensory areas include the sight and sound processing areas (occipital + auditory lobes). Associative areas are language centers and areas that process caution (frontal lobe).
a. LSD changes how the brain talks to itself
b. It makes some areas talk more with themselves than with the net, and some talk more with the net than themselves.
c. The sensory areas (sight and sound processing) fire less with each other and more with the rest of the brain on fMRI images. This makes sight and sound more appealing, because they can bring up a complex web of emotions and memories.
d. The associative areas (language, caution, and social conditioning) talk less with the rest of the brain and more locally. Implications were not discussed, but theoretically this could help remove some of the mental barriers to therapy.
e. Communication is especially strong between the visual and emotional centers, and weak between these and the language and caution centers. The net effect is a state of less judgement on visual cues. This can be positive (accepting other people) or negative (not recognizing damaging actions).
XII. Impact on fear varies by substance
a. In a depressed brain, an area called the amygdala shows greater activity for negative stimulation than for neutral stimulation. An interaction the average person would brush off is instead taken as personal rejection. This is modulated by an area known as the social pain center (dorsal VM cortex). An experiment was made in which neutral and negative stimulation were given around social inclusion and isolation.
b. Mushrooms and MDMA reduce activity in the social pain center
c. While neurologically similar, given follow up questions MDMA users did not understand they were being isolated. Mushroom users understood they were being isolated, but were not bothered by it.
d. This presents an "is ignorance bliss" ethical debate about the use of MDMA for treatment of anxiety and depression.
e. Other 5HT2a drugs help with fear extinguishing in the hippocampus as well as the amygdala.
XIII. Cluster headaches
a. An extremely painful disability with one of the highest rates of suicide, psychadelic research has shown that cluster headaches are caused by an immune response (TNF) which causes inflammation (via cytokines) in an attempt to protect the body - from itself.
b. 5HT2a stimulation STRONGLY inhibits TNF. There are no other things which do this.
c. It is not a cure, but helps reduce suffering to managable levels
d. There is some success with other inflammation disorders like Chrone's and IBS
XIV. CBD vs THC on mood and sleep disorders
a. THC is a turn up drug. It generally does not help mood disorders on fMRI imaging or in self report. At 15mg doses it disrupts Stage 3 sleep, causing people to feel groggy when they get up.
b. In contrast, CBD has a large medicinal reach
i. For fear, CBD quiets the amygdala and hippocampus
ii. It lowers stimulation in D2 psychosis.
iii. It lowers the fx of schizophrenia by increasing anadamine
iv. It reduces nightmares without change to sleep cycles
v. It does not fix imsomnia, but impacted how often patients worried about it, improving their quality of life
vi. THC withdraw is seen in some as a four day period of extreme anxiety. CBD helps to manage this, and does not have a withdraw period.
vii. There are some reports of CBD assisting in opiate withdraw symptoms.
XV. Music enhances drug treatment. Many feel taken on a journey by music that is played for them. This is likely due to the cross between the emotional and auditory centers. It was equally reported as positive and negative as an experience. Drug + music effects on relief for mood disorders faded after one week.
XVI. Studying hundreds of people, the intensity of a hallucinogenic drug experience varies over time in a graph that looks like a steep mountain range. States shift between dream like realities and lucid moments. 90% experience different sensations in sight, sound, or touch. 8% have mental insights into how they interact with the world. Given the amount of reports on how much substance interactions have changed people's mindsets, it is surprisingly rare in the total population. For this reason, dual therapy with guided assistance is encouraged.
My notes:
There is a lot of room for abuse in this methodology. The experience of Brian Wilson of the Beach Boys is a key case study in destructive guidance. Therapists should be ethically well vetted.
I also have to wonder if there is a chemical more politically accepted that could produce glutamate and BDNF.
In summary: low dosing LSD seems the most effective with the least side effects for treatment resistant mood disorders. CBD is a great short term relief compound specific to anxiety and withdraw. All these drugs, to some extent, are showing medicinal value. It is a great time for research!
No comments:
Post a Comment